| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |